Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Denmark Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20051
20061
20071
20081
20091
20101
20111
20122
20132
20141
20162
20171
20182
20193
20222
20232
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated8
Recruiting6
Active, not recruiting4
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
GlaxoSmithKline3
Amgen2
AstraZeneca2
Eli Lilly and Company2
Pfizer2
Sanofi2
United Therapeutics2
Abbott Medical Devices1
Alnylam Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases36
Heart Diseases8
Stroke8
Myocardial Infarction7
Atherosclerosis6
Hypertension5
Coronary Artery Disease4
Coronary Disease4
Diabetes Mellitus, Type 24
Heart Failure4

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.